HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health
Description
This grant aims to enhance HIV/AIDS prevention strategies for populations affected by alcohol use, who face varying levels of risk for HIV. It supports research needed to plan a clinical trial related to HIV prevention and alcohol, showing that this preliminary research is crucial for designing the trial. The grant will fund projects that provide sufficient results to inform a future trial, focusing primarily on testing the effectiveness and safety of intervention methods to prevent HIV. The…
The NOFO seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions wit…
Source
Grant ID
PAS-25-161
Agency
National Institutes of Health
Subcategory/Subagency
National Institute on Alcohol Abuse and Alcoholism
Key Dates
Opportunity Released
November 25, 2024
Awards & Funding
Total Funding
$225,000
Award Ceiling
$450,000
Funding Amount
~$450,000
Similar opportunities
- HIV Prevention and Alcohol (R34 Clinical Trials Optional)
National Institutes of Health
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
- Notice of Funding Opportunity for Research on Interventions for People Who Use Drugs
National Institutes of Health
- HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institutes of Health
- Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
Department of Health and Human Services